Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period from May 1, 2009, to October 31, 2009. The document serves as a Block Listing Six Monthly Return, detailing the status of various employee share option schemes. It does not contain general business operations updates or financial performance data for the period.
Key Financial Metrics
The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the number of securities allotted and the remaining balance of unallotted securities under specific share option plans.
Material Changes in Share Option Schemes
The following changes occurred in the unallotted securities balances between the previous return and the end of the reporting period:
- GlaxoSmithKline Share Option Plan - Ordinary Shares: Decreased by 268,191 shares (from 5,295,707 to 5,027,516).
- GlaxoSmithKline Share Option Plan - ADS: Decreased by 363,648 shares (from 6,389,424 to 6,025,776).
- GlaxoSmithKline Savings Related Share Option Scheme: Decreased by 73,735 shares (from 5,264,981 to 5,191,246).
- Other Schemes: No securities were issued or allotted during the period for the Glaxo Wellcome UK, Glaxo Wellcome International, Glaxo Wellcome 1999, or SmithKline Beecham 1989 plans. Balances remained unchanged.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document is a statutory report regarding equity compensation plan administration.
Key Facts for Investor Verification
- Verify the total number of shares issued under the GlaxoSmithKline Share Option Plan (Ordinary and ADS) during the six-month period, totaling 631,839 shares.
- Confirm that no new shares were added to the block listing for any scheme during this period (all increases were zero).
- Note that the majority of the company's share option schemes (5 out of 9 listed) had zero activity in terms of new issuances during this period.
- Check the remaining pool of unallotted securities, which totals approximately 35.9 million shares across all listed schemes.